Le Lézard
Classified in: Health, Science and technology

73% of Respondents Say One or More Diseases Run in Their Family; Just 6% Don't Want Genetic Testing -- Wamberg Genomic Survey


LA JOLLA, Calif., Dec. 7, 2017 /PRNewswire/ -- Seventy-three percent of respondents noted that common diseases run in their family.  The top diseases cited were diabetes 37%, cancer 35%, heart disease 32%, and depression/mental health issues 31%.  Just 6% would decline free genetic testing to better predict future occurrence of diseases. Fifty-three percent (53%) of respondents noted that they would definitely accept free genetic testing to better predict future occurrence of diseases, another 29% may want it, and 12% were unsure.

Wamberg Genomic Advisors' mission is to make genomic testing readily available at prices everyone can afford. The firm's focus is on delivering genomic products and services to employers and their employees via their trusted benefit brokers, and policyholders of life insurance companies (PRNewsfoto/Wamberg Genomic Advisors)

Results are based on Wamberg Genomic Consumer Survey, which queried 536 U.S. consumers from 26 to 64 years old with employer-sponsored health insurance. Survey Sampling International (SSI) fielded the survey in October/November 2017.

According to Dr. Phil Smalley, Chief Medical Director of Wamberg Genomic Advisors, "These results indicate that the public seems to understand that knowing their genetics can help lower their risk of developing diseases that run in their family."

Results from the survey questions are below:

Do any of these diseases run in your family? *

If you were offered free genetic testing to better predict future occurrence of diseases and the results were private and confidential, would you want to get your own genetics tested?

For the first time, individuals and their families can access the following tests and reports to help their care providers better manage health:

Other results of the survey revealed the following:

About the Survey
The Wamberg Genomic Consumer Survey queried 536 U.S. consumers 26-64. The survey was fielded by Survey Sampling International (SSI) in October/November 2017. Data for the survey was collected via an opt-in panel. The margin of error was 4%.

About Survey Sampling International:

Survey Sampling International (SSI) has been the premier global provider of data solutions and technology for consumer and business-to-business survey research for 40 years.  For more information, go to www.surveysampling.com.   

About Wamberg Genomic Advisors:

Wamberg Genomic Advisors' mission is to make genomic testing readily available at prices everyone can afford. Our focus is on delivering genomic products and services to employers and their employees via their trusted benefit brokers, and policyholders of life insurance companies. To learn more, visit wamberggenomic.com.

*Note percentages can add to more than 100% as respondents can choose multiple answers

SOURCE Wamberg Genomic Advisors


These press releases may also interest you

at 15:30
Remofirst today announced that it was named a Most Loved Workplace®, based on certification and analysis of the Best Practice Institute (BPI). The Most Loved Workplace® validation provides the most comprehensive look at workplace sentiment for...

at 15:29
Dye & Durham Limited ("Dye & Durham" or the "Company"), one of the world's largest providers of cloud-based legal practice management software designed to make managing a law firm, organizing cases, and collaborating with clients easy, today...

at 15:20
After careful review of hundreds of applications, NASA has selected organizations from across the country to receive 'Moon Tree' seedlings that flew around the Moon on the agency's Artemis I mission in 2022, to plant in their communities....

at 15:06
REI Path Ahead Ventures is celebrating 16 emerging companies completing its Embark program, bringing the latest products and experiences to the outdoor industry. Embark is a three-month curriculum created in partnership with Founded Outdoors to...

at 15:00
BrainSell, the growth enablement company specializing in helping clients grow with top-of-the-line business technology solutions, has promoted Kevin Cook to Chief Technology Officer (CTO). Cook's 15 years at BrainSell, working across business...

at 14:54
Ferrilli, a leading provider of technology solutions for higher education institutions, proudly announces its recognition as the Ellucian Implementation Partner of the Year for 2023. This esteemed award marks the second consecutive year that Ferrilli...



News published on and distributed by: